University of Dundee
|
|
- Dustin Quinn
- 6 years ago
- Views:
Transcription
1 University of Dundee Cardiovascular Epidemiology Unit Why Scotland is adding Social Deprivation and Family History to cardiovascular risk assessment in the ASSIGN score H. Tunstall-Pedoe
2 University of Dundee Cardiovascular Epidemiology Unit on behalf of SIGN working group on risk estimation
3 SOCIAL DEPRIVATION = SIMD (Scottish Index of Social Deprivation) Postcodes 208,609 Range of SIMD for postcodes = 0.94 to Mean 21.21, STD 16.32, Median
4 SIMD LOOK-UP TABLE AB1 0NA 9.06 AB1 0NB 9.37 AB1 0ND 9.37 AB1 0NE 4.36 AB1 0NJ 6.65 AB1 0NL 6.65 AB1 0NN 9.84 AB1 0NP 6.65 AB1 0NQ 4.36 Etcetera 208, 600 more!!!
5
6
7
8 Millionaires row Hermitage Drive, Edinburgh, EH10 6BZ SIMD = 1.14
9
10
11
12 Social deprivation row Torr St, Possil, Glasgow G22 5EE SIMD = 87.61
13 ASSIGN ASSessing cardiovascular risk using SIGN guidelines to ASSIGN preventive treatment SIGN= Scottish Intercollegiate Guidelines Network
14 Further information Website assign-score.com Publications Heart 2006; 92: Heart 2007; 93: 172-6
15 Purpose First premiss The purpose of cardiovascular risk scores is not primarily the prediction of individual risk. Second premiss It is to prioritize giving preventive treatment to those at greatest risk. Third premiss Scores are inherently discriminatory but need to discriminate fairly.
16 Purpose Fourth premiss This means that everyone above the chosen cut-point for preventive treatment should be at higher risk than everyone below it. Fifth premiss Social and ethnic variation in cardiovascular risk is inadequately explained by classic cardiovascular risk factors
17 Purpose Sixth premiss If cardiovascular risk scoring is to be applied to whole populations it may need to take account of social and ethnic heterogeneity within those populations.
18 Questions Question one Is the Framingham cardiovascular score fair (or equitable) when used across a socially heterogeneous population? Question two Can we devise a more socially equitable cardiovascular risk score which performs better than Framingham?
19 Methods Scottish Heart Health Extended Cohort (SHECC):random population samples recruited Identification of Scottish Index of Multiple Deprivation (SIMD) from postcode (=Zipcode) of address at recruitment.
20 Methods Follow-up of mortality and morbidity through national registries and record linkage. Cardiovascular mortality and hospital diagnoses of CHD, CBVD, and TIA to end of 2005 (= years follow-up)
21 Methods Calculation of observed rates by fifths of SIMD score. Expected rates calculated from Framingham cardiovascular score. Compare them to assess performance of Framingingham score with respect to social equity.
22 Question one results 6540 men, 1604 developed CVD, 743 within 10 years 6757 women, 1015 developed CVD, 422 within 10 years
23 CVD 10y risk percent Framingham O & E Men O RR E RR O/E RR Women
24 Results Question One Compared with the population mean, use of the standard Framingham score results in undertreatment of the socially deprived and overtreatment of the socially advantaged. It is therefore unfair. The effect is relatively greater in women than men, the former having a greater social gradient (relatively) in disease.
25 Methods Question Two Use the same database to derive a risk score incorporating deprivation with the classic risk factors and any others that prove significant when tested. Compare performance of the new ASSIGN score with the Framingham cardiovascular score within the SHHEC cohort.
26 Methods Question 2 Cox proportional hazards model Test for linearity of risk factors Kaplan-Meier estimate of survival Observed versus expected, rank correlation, Kappa statistics, discrimination, area under ROC curve, HOTH graph
27 Results Question Two SIMD score was significant + Family history was significant + Cigarette dosage was significant + Left ventricular hypertrophy not so Body mass index not so
28 Results: Calibration Incidence (observed) = 11.7% (MEN) Framingham mean = 16.0% ASSIGN mean = 14.4% Framingham median = 13.6% ASSIGN median = 11.7%
29 Results: Calibration Incidence (observed) = 6.4% (WOMEN) Framingham mean = 9.6% ASSIGN mean = 9.3% Framingham median = 7.1% ASSIGN median = 6.2%
30 Results: comparison Rank correlation 0.92 in men, 0.90 in women Kappa statistics: at 20% cutoff 0.75 ( ) at 30% cutoff 0.59 ( )
31 Results: comparison Correct allocation in SHHEC cohort ASSIGN 83% at 20% cutoff Framingham 79%. ASSIGN 96% at 30% cutoff Framingham 89%...
32 Results: Area under the ROC Men curve for ASSIGN for Framingham (p= 0.02) Women for ASSIGN for Framingham (p= )
33
34 CVD 10y risk percent ASSIGN O & E Men O RR E RR O/E RR Women
35 Cases treated or not % of whole group at 20% treated overall SIMD Fram +ve -ve ASSN +ve -ve ALL
36 Conclusions Framingham and other current scores ignore that component of social and ethnic risk which is not mediated by the classic risk factors. Through a deprivation score and family history ASSIGN addresses deprivation directly and ethnicity indirectly.
37 Conclusions ASSIGN and Framingham perform quite similarly in tests of discrimination: adding new powerful risk factors adds little to overall discrimination. ASSIGN is not therefore much better overall, but it is more equitable between social groups and is being adopted in Scotland for that reason.
38 Conclusions ASSIGN was designed for a Scottish population but could be calibrated for others which have an index of social deprivation. Others are copying us (cf QRISK recent BMJ) but we were the first to include a measure of social deprivation.
39 Workload :% of SHHEC popn above 20% 10y risk SIMD Fram ASSN Men All Women All
40 Further information Website assign-score.com Publications Heart 2006; 92: Heart 2007; 93: 172-6
41 SHHEC ASSIGN Age last birthday: 52 years Sex : enter "M" or "F" m SIMD score Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 19 FramCV 27 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,
42 SHHEC ASSIGN Age last birthday: 52 years Sex : enter "M" or "F" m SIMD score 1.1 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 17 FramCV 27 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,
43 SHHEC ASSIGN Age last birthday: 52 years Sex : enter "M" or "F" m SIMD score 85 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 27 FramCV 27 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,
44 SHHEC ASSIGN Age last birthday: 58 years Sex : enter "M" or "F" f SIMD score Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 19 FramCV 25 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,
45 SHHEC ASSIGN Age last birthday: 58 years Sex : enter "M" or "F" f SIMD score 1.1 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 16 FramCV 25 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,
46 SHHEC ASSIGN Age last birthday: 58 years Sex : enter "M" or "F" f SIMD score 85 Family history:"y" or "N" n Diabetes:"Y" or "N" n Current cig. smoker: "Y" or "N" y no/day 20 Systolic blood pressure (SBP): 140 mmhg Total cholesterol 6.5 mmol/l HDL cholesterol 1.2 mmol/l SHHEC ASSIGN score 31 FramCV 25 Authors: Mark Woodw ard and Hugh Tunstall Pedoe,
AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE
AN INDEPENDENT VALIDATION OF QRISK ON THE THIN DATABASE Dr Gary S. Collins Professor Douglas G. Altman Centre for Statistics in Medicine University of Oxford TABLE OF CONTENTS LIST OF TABLES... 3 LIST
More informationRESEARCH. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study Julia Hippisley-Cox, professor of clinical epidemiology and general practice,
More informationSupplemental tables/figures
Supplemental tables/figures Table S:Baseline variables included in calculation of QRISK and Framingham scores Ethnicity (European, Indian Pakistani, Bangladeshi, Black African, Black Caribbean) QRISK Age,
More informationShould we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand
Should we base treatment decisions on short-term or lifetime CVD risk? Rod Jackson University of Auckland New Zealand Presentation outline Strengths & weaknesses of short-term risk approach Strengths &
More informationLifetime vs. 10-year risk to allocate treatments for the primary prevention of cardiovascular disease
Lifetime vs. 10-year risk to allocate treatments for the primary prevention of cardiovascular disease Eleni Rapsomaniki Farr Institute for Health Informatics Research, Epidemiology & Public Health University
More informationDerivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
EDITORIAL by Bonneux 1 Tower Building, University Park, Nottingham NG2 7RD 2 Centre for Health Sciences, Queen Mary s School of Medicine and Dentistry, London 3 Department of Social Medicine, University
More informationCardiovascular risk factor appraisal art or science?
Cardiovascular risk factor appraisal art or science? Prof. Philip MacCarthy BSc MBChB (Hons) PhD FRCP Consultant Cardiologist Bupa Cromwell Hospital Clinics: Wednesday & Friday PM/Evening What are we trying
More informationQStatin Update Information
QStatin -2014 Update Information Revision History Revision date Document Version Summary of Changes 19.08.2014 V1.0 First issue. Contents 1 Purpose of document... 3 2 Rationale for regular updates of QStatin...
More informationRESEARCH. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore
Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore Julia Hippisley-Cox, professor of clinical epidemiology and general practice, 1 Carol Coupland,
More informationCorrelation of novel cardiac marker
Correlation of novel cardiac marker and mortality in EGAT population. Soluble ST2 hscrp Poh Chanyavanich, MD SukitYamwong, MD Piyamitr Sritara, MD Ramathibodi hospital Background hscrp - the most widely
More informationValidation of QRISK2 (2014) in patients with diabetes
Validation of QRISK2 (2014) in patients with diabetes Authors Julia Hippisley-Cox Professor of Clinical Epidemiology & General Practice 1 Carol Coupland Associate Professor and Reader in Medical Statistics
More informationwell-targeted primary prevention of cardiovascular disease: an underused high-value intervention?
well-targeted primary prevention of cardiovascular disease: an underused high-value intervention? Rod Jackson University of Auckland, New Zealand October 2015 Lancet 1999; 353: 1547-57 Findings: Contribution
More informationDiscontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database
open access Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database Yana Vinogradova, 1 Carol Coupland, 1 Peter Brindle, 2,3 Julia Hippisley-Cox
More informationK D Lawson, 1 E A L Fenwick, 1 A C H Pell, 2 J P Pell 1. Epidemiology
See Editorial, page 177 1 Section of Public Health, University of Glasgow, UK 2 Monklands Hospital, Airdrie, UK Correspondence to Professor Jill Pell, Room 305, Public Health Section, University of Glasgow,
More informationRESEARCH. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 Julia Hippisley-Cox, professor of clinical epidemiology and general practice, 1 Carol Coupland, senior
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationSince 1980, obesity has more than doubled worldwide, and in 2008 over 1.5 billion adults aged 20 years were overweight.
Impact of metabolic comorbidity on the association between body mass index and health-related quality of life: a Scotland-wide cross-sectional study of 5,608 participants Dr. Zia Ul Haq Doctoral Research
More informationRisk modeling for Breast-Specific outcomes, CVD risk, and overall mortality in Alliance Clinical Trials of Breast Cancer
Risk modeling for Breast-Specific outcomes, CVD risk, and overall mortality in Alliance Clinical Trials of Breast Cancer Mary Beth Terry, PhD Department of Epidemiology Mailman School of Public Health
More informationKey causes of preventable deaths in New Zealand In a population of 10,000 New Zealanders, every year there will be about:
Preventive care - Chronic Disease Management in primary care: a population perspective Rod Jackson University of Auckland New Zealand (22/11/8) Key causes of preventable deaths in New Zealand In a population
More informationNew approaches to the implementation of cardiovascular disease prevention Jørstad, H.T.
UvA-DARE (Digital Academic Repository) New approaches to the implementation of cardiovascular disease prevention Jørstad, H.T. Link to publication Citation for published version (APA): Jørstad, H. T. (2016).
More informationCOMPETING INTEREST OF FINANCIAL VALUE
BHIVA AUTUMN CONFERENCE 2012 Including CHIVA Parallel Sessions Dr Duncan Churchill Royal Sussex County Hospital, Brighton COMPETING INTEREST OF FINANCIAL VALUE > 1,000: Speaker Name Statement Duncan Churchill
More informationSecondary analyses of HSE data and linked health outcomes - an overview of work in progress. UCL (University College London)
Secondary analyses of HSE data and linked health outcomes - an overview of work in progress Dr Jennifer Mindell, UCL (University College London) Linked HSE mortality data (2008) In 2008, some mortality
More informationCoronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study
Coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC) study A. Attached below are the beta coefficients from the Cox regression models for the full models presented in
More informationFamily history of premature coronary heart disease and risk prediction in the EPIC-Norfolk prospective population study
1 Department of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands 2 Department of Cardiology, Academic Medical Center, Amsterdam, The Netherlands 3 Department of Public Health and
More informationQDScore 2011 Annual Update Information
QDScore 2011 Annual Update Information Revision History Revision date Document Version Summary of Changes 01 Jan 2011 V1.0 First issue. Contents 1 Purpose of document... 1-3 2 Rational for annual updates...
More informationRESEARCH. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study
An independent external validation and evaluation of cardiovascular risk prediction: a prospective open cohort study Gary S Collins, medical statistician, 1 Douglas G Altman, professor of statistics in
More informationA lthough the hazards of smoking are well described,
702 RESEARCH REPORT Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12 149 men and women in The Copenhagen City Heart
More informationEuroPrevent 2010 Fatal versus total events in risk assessment models
EuroPrevent 2010 Fatal versus total events in risk assessment models Pekka Jousilahti, MD, PhD,Research Professor National Institute for Health and Welfare, Finland Risk assessment models Estimates the
More informationScottish mental health profiles for adults: summary report. Andrew D Millard, Gerry McCartney
Scottish mental health profiles for adults: summary report Andrew D Millard, Gerry McCartney November 2015 We are happy to consider requests for other languages or formats. Please contact 0131 314 5300
More informationPreventing Cardiovascular Disease Stroke Primary Prevention Guidelines. John Potter Professor Ageing & Stroke Medicine University of East Anglia
Preventing Cardiovascular Disease Stroke Primary Prevention Guidelines John Potter Professor Ageing & Stroke Medicine University of East Anglia Preventing Cardiovascular Disease Stroke Primary Prevention
More informationDiabetes, Diet and SMI: How can we make a difference?
Diabetes, Diet and SMI: How can we make a difference? Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Relative
More informationRESEARCH. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study
Centre for Statistics in Medicine, Wolfson College Annexe, University of Oxford, Oxford OX2 6UD Correspondence to: G Collins gary.collins@csm.ox.ac.uk Cite this as: BMJ 2010;340:c2442 doi:10.1136/bmj.c2442
More informationCVD risk assessment using risk scores in primary and secondary prevention
CVD risk assessment using risk scores in primary and secondary prevention Raul D. Santos MD, PhD Heart Institute-InCor University of Sao Paulo Brazil Disclosure Honoraria for consulting and speaker activities
More informationLifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study
Lifetime clinical and economic benefits of statin-based LDL lowering in the 20-year Followup of the West of Scotland Coronary Prevention Study Harvey White Green Lane Cardiovascular Service and Cardiovascular
More informationVascular Diseases. Overview: Selected Slides
Vascular Diseases Overview: Selected Slides Total deaths and change in vascular death rates
More informationOptimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden
Optimizing risk assessment of total cardiovascular risk What are the tools? Lars Rydén Professor Karolinska Institutet Stockholm, Sweden Cardiovascular Disease Prevention (CVD) Three Strategies for CVD
More informationPopulation base eye screening in Scotland. Challenges of equity and coverage. Graham Leese University of Dundee
Population base eye screening in Scotland. Challenges of equity and coverage Graham Leese University of Dundee Edinburgh July 16 th 2018 NUMBER OF PATIENTS RECEIVING LASER IN TAYSIDE 300 250 200 Number
More informationBaldness and Coronary Heart Disease Rates in Men from the Framingham Study
A BRIEF ORIGINAL CONTRIBUTION Baldness and Coronary Heart Disease Rates in Men from the Framingham Study The authors assessed the relation between the extent and progression of baldness and coronary heart
More informationPreventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex
Prevention and Rehabilitation Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex Nathan D. Wong, PhD, a Gaurav Thakral, BS, a Stanley S. Franklin,
More informationWhat have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline?
What have We Learned in Dyslipidemia Management Since the Publication of the 2013 ACC/AHA Guideline? Salim S. Virani, MD, PhD, FACC, FAHA Associate Professor, Section of Cardiovascular Research Baylor
More informationUsing Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly
Using Cardiovascular Risk to Guide Antihypertensive Treatment Implications For The Pre-elderly and Elderly Paul Muntner, PhD MHS Professor and Vice Chair Department of Epidemiology University of Alabama
More informationCVD Prevention, Who to Consider
Continuing Professional Development 3rd annual McGill CME Cruise September 20 27, 2015 CVD Prevention, Who to Consider Dr. Guy Tremblay Excellence in Health Care and Lifelong Learning Global CV risk assessment..
More informationCardiovascular Risk Assessment and Management Making a Difference
Cardiovascular Risk Assessment and Management Making a Difference Norman Sharpe March 2014 Numbers and age-standardised mortality rates from all causes, by sex, 1950 2010 Death rates halved Life expectancy
More information1210 factors. However, it refers to the fact that CVD, in most people, is the product of several risk AUROC ⴝ area under the factors that may interact
Journal of the American College of Cardiology 2009 by the American College of Cardiology Foundation Published by Elsevier Inc. Vol. 54, No. 14, 2009 ISSN 0735-1097/09/$36.00 doi:10.1016/j.jacc.2009.07.020
More informationSPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units)
SPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units) A report on the work to identify patients at greatest risk of readmission and admission
More informationDevelopment and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
open access Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study Julia Hippisley-Cox, 1 Carol Coupland, 1 Peter Brindle
More informationKjersti Stormark Rabanal, 1 Haakon Eduard Meyer, 1,2 Romana Pylypchuk, 3 Suneela Mehta, 3 Randi Marie Selmer, 1 Rodney T Jackson 3.
Open access Additional material is published online only. To view, please visit the journal online (http:// dx. doi. org/ 10. 1136/ openhrt- 2018-000821). To cite: Rabanal KS, Meyer HE, Pylypchuk R, et
More informationEpidemiologic Measure of Association
Measures of Disease Occurrence: Epidemiologic Measure of Association Basic Concepts Confidence Interval for population characteristic: Disease Exposure Present Absent Total Yes A B N 1 = A+B No C D N 2
More informationEffectiveness of statins in chronic kidney disease
Q J Med 2012; 105:641 648 doi:10.1093/qjmed/hcs031 Advance Access Publication 29 February 2012 Effectiveness of statins in chronic kidney disease X. SHENG 1, M.J. MURPHY 2, T.M. MACDONALD 1 and L. WEI
More informationDevelopment and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study
Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study Julia Hippisley-Cox, 1,2 Carol Coupland 1 1 Division of Primary Care, University
More informationModelling Reduction of Coronary Heart Disease Risk among people with Diabetes
Modelling Reduction of Coronary Heart Disease Risk among people with Diabetes Katherine Baldock Catherine Chittleborough Patrick Phillips Anne Taylor August 2007 Acknowledgements This project was made
More informationScreening for Cardiovascular Risk in Asymptomatic Patients
Journal of the American College of Cardiology Vol. 55, No. 12, 2010 2010 by the American College of Cardiology Foundation ISSN 0735-1097/10/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2009.09.066
More informationScottish Diabetes Survey
Scottish Diabetes Survey 2008 Scottish Diabetes Survey Monitoring Group Foreword The information presented in this 2008 Scottish Diabetes Survey demonstrates a large body of work carried out by health
More informationORIGINAL ARTICLE. Epidemiology
ORIGINAL ARTICLE Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE Southall And Brent REvisited) Therese
More informationEurope PMC Funders Group Author Manuscript Heart. Author manuscript; available in PMC 2016 May 17.
Europe PMC Funders Group Author Manuscript Published in final edited form as: Heart. 2014 January ; 100(1): 60 67. doi:10.1136/heartjnl-2013-304474. Ethnicity and prediction of cardiovascular disease:
More informationCreating a Tobacco-Free Scotland: Addressing the Inequalities Challenge
Creating a Tobacco-Free Scotland: Addressing the Inequalities Challenge Amanda Amos Centre for Population Health Sciences University of Edinburgh Outline What are the issues and challenges- patterns and
More informationCoronary heart disease statistics edition. Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner
Coronary heart disease statistics 2007 edition Steven Allender, Viv Peto, Peter Scarborough, Anna Boxer and Mike Rayner Health Promotion Research Group Department of Public Health, University of Oxford
More informationCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women
European Heart Journal (2002) 23, 528 535 doi:10.1053/euhj.2001.2888, available online at http://www.idealibrary.com on Combined effects of systolic blood pressure and serum cholesterol on cardiovascular
More informationThe polypill in the primary prevention of cardiovascular disease
doi: 10.1111/j.1472-8206.2009.00795.x REVIEW ARTICLE The polypill in the primary prevention of cardiovascular disease David S. Wald*, Nicholas J. Wald Wolfson Institute of Preventive Medicine, Barts and
More informationAssessing the economics of a stratified treatment approach for Type 2 Diabetes
Assessing the economics of a stratified treatment approach for Type 2 Diabetes A. Green 1, A. Gray 4, R. Holman 4, A. Farmer 4, N. Sattar 5, A. Jones 3, A. Hattersley 3, E. Pearson 2, C. Jennison 1, 1
More information. Time to transplant listing is dependent on. . In 2003, 9.1% of all prevalent transplant. . Patients with diabetes mellitus are less
Chapter 5: Joint Analyses with UK Transplant in England and Wales; Access to the Renal Transplant Waiting List, Time to Listing, Diabetic Access to Transplantation and the Influence of Social Deprivation
More informationIndividual Participant Data (IPD) Meta-analysis of prediction modelling studies
Individual Participant Data (IPD) Meta-analysis of prediction modelling studies Thomas Debray, PhD Julius Center for Health Sciences and Primary Care Utrecht, The Netherlands March 7, 2016 Prediction
More informationDeveloping and validating a cardiovascular risk score for patients in the community with prior
Developing and validating a cardiovascular risk score for patients in the community with prior cardiovascular disease Poppe: CV risk score in prior CVD 1,2 Katrina K Poppe 2,3 Rob N Doughty 1 Sue Wells
More informationLung cancer: the importance of seeing a respiratory physician
Eur Respir J 2003; 21: 606 610 DOI: 10.1183/09031936.03.00060803 Printed in UK all rights reserved Copyright #ERS Journals Ltd 2003 European Respiratory Journal ISSN 0903-1936 Lung cancer: the importance
More informationDepok-Indonesia STEPS Survey 2003
The STEPS survey of chronic disease risk factors in Indonesia/Depok was carried out from February 2003 to March 2003. Indonesia/Depok carried out Step 1, Step 2 and Step 3. Socio demographic and behavioural
More informationetable 3.1: DIABETES Name Objective/Purpose
Appendix 3: Updating CVD risks Cardiovascular disease risks were updated yearly through prediction algorithms that were generated using the longitudinal National Population Health Survey, the Canadian
More informationDiabetes MAYER B. DAVIDSON, MD,* CO-EDITOR-IN-CHIEF; HENRY N. GINSBERG, MD, REVIEWER; TERRENCE F. FAGAN, MANAGING EDITOR; CHING-LING CHEN, PhD, WRITER
Professional Postgraduate Services Release Date: March 14, 2008 Valid Through: July 14, 2008 Sponsor This educational activity is a component of the National Diabetes Education Initiative (NDEI ), sponsored
More informationThe effect of blood pressure and cholesterol variability on the precision of Framingham cardiovascular risk estimation: a simulation study
(2010) 24, 631 638 & 2010 Macmillan Publishers Limited All rights reserved 0950-9240/10 www.nature.com/jhh ORIGINAL ARTICLE The effect of blood pressure and cholesterol variability on the precision of
More informationAppendix S1. List of Figures. List of Tables
Appendix S1 List of Figures S1 Comparison of death rates in RealAge sample to US death rates...................... 1 S2 RealAge delta in California sample with full identifiers..........................
More informationThe value of stratified economic analysis in cohort-level models: A case study on interventions for obstructive sleep apnea
The value of stratified economic analysis in cohort-level models: A case study on interventions for obstructive sleep apnea BERNICE TSOI AND KAREN LEE CADTH Disclosure No actual or potential conflict of
More informationOnline Appendix (JACC )
Beta blockers in Heart Failure Collaborative Group Online Appendix (JACC013117-0413) Heart rate, heart rhythm and prognostic effect of beta-blockers in heart failure: individual-patient data meta-analysis
More informationAmbulatory arterial stiffness index as a predictor of cardiovascular events.
Ambulatory arterial stiffness index as a predictor of cardiovascular events. A meta-analysis of longitudinal studies. Konstantinos Aznaouridis, Charalambos Vlachopoulos, Christodoulos Stefanadis. 1 st
More informationCVD Risk Assessment. Michal Vrablík Charles University, Prague Czech Republic
CVD Risk Assessment Michal Vrablík Charles University, Prague Czech Republic What is Risk? A cumulative probability of an event, usually expressed as percentage e.g.: 5 CV events in 00 pts = 5% risk This
More informationHigh-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients with Stable Coronary Heart Disease: KAROLA Study 8 Year FU
ESC Congress 2011 Paris, France, August 27-31 KAROLA Session: Prevention: Are biomarkers worth their money? Abstract # 84698 High-sensitivity Troponin T Predicts Recurrent Cardiovascular Events in Patients
More informationWhy Do We Treat Obesity? Epidemiology
Why Do We Treat Obesity? Epidemiology Epidemiology of Obesity U.S. Epidemic 2 More than Two Thirds of US Adults Are Overweight or Obese 87.5 NHANES Data US Adults Age 2 Years (Crude Estimate) Population
More informationEconomically efficient approaches to address chronic disease in developing countries
Economically efficient approaches to address chronic disease in developing countries Thomas A. Gaziano MD MSc Division of Cardiovascular Medicine Brigham & Women s Hospital Harvard Medical School Center
More informationA REPORT PREPARED FOR THE UK NATIONAL SCREENING COMMITTEE
A REPORT PREPARED FOR THE UK NATIONAL SCREENING COMMITTEE BY MELANIE DAVIES KAMLESH KHUNTI UMESH CHAUHAN BERNIE STRIBLING ELIZABETH GOYDER AZHAR FAROOQI JAYNE HILL STEVE HILES NICK TAUB MARIAN CAREY MICHAEL
More informationIdentification of subjects at high risk for cardiovascular disease
Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April 14 2011 Identification of subjects at high risk for cardiovascular disease Lars Rydén Karolinska Institutet
More informationThe management of diabetes
MEDICINE DIGEST STATINS The management of diabetes should include efforts to prevent, or delay, the onset of cardiovascular disease. Statins have been shown to lower cardiovascular risk in diabetes and
More informationEuropean Journal of Cardiovascular Prevention & Rehabilitation
European Journal of Cardiovascular Prevention & Rehabilitation http://cpr.sagepub.com/ Prevalence of cardiovascular disease risk amongst the population eligible for the NHS Health Check Programme Andrew
More informationESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study
ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study Statistical modelling details We used Cox proportional-hazards
More informationNICE Indicator Programme. Consultation on proposed amendments to current QOF indicators
NICE Indicator Programme Consultation on proposed amendments to current QOF s Consultation dates: 18 July to 1 August 2018 This document outlines proposed amendments to a small number of QOF s in the diabetes
More informationHeart Age and Cardiovascular Risk
Heart Age and Cardiovascular Risk Mark Cobain Unilever R+D Colworth Science Park Sharnbrook Bedfordshire Europrevent, Geneva April 16 2011 Conflict of Interest Statement Employment by Unilever PLC A producer
More informationSarah J. E. Barry 1 *, Eleanor Dinnett 2, Sharon Kean 1, Allan Gaw 3, Ian Ford 1. Abstract. Introduction
Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention Study Sarah J. E. Barry 1 *, Eleanor Dinnett
More informationDeposited on: 2 June 2010
Thompson, H.J. and Pell, A.C.H. and Anderson, J. and Chow, C.K. and Pell, J. (2010) Screening families of patients with premature coronary heart disease to identify avoidable cardiovascular risk: a cross-sectional
More informationDiabetes Mellitus: A Cardiovascular Disease
Diabetes Mellitus: A Cardiovascular Disease Nestoras Mathioudakis, M.D. Assistant Professor of Medicine Division of Endocrinology, Diabetes, & Metabolism September 30, 2013 1 The ABCs of cardiovascular
More informationSupplementary Online Content
Supplementary Online Content Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among people with and without diabetes. JAMA. doi:10.1001/jama.2013.1644.
More informationHEALTH TARGETS IN PRIMARY CARE
HEALTH TARGETS IN PRIMARY CARE MORE HEART AND DIABETES CHECKS BETTER HELP FOR SMOKERS TO QUIT Better Help for Smokers to Quit 90% of enrolled patients who smoke and are seen by General Practice, will be
More informationHow do we protect from the harms of second-hand smoke [SHS]?
How do we protect from the harms of second-hand smoke [SHS]? Sean Semple Respiratory Group, University of Aberdeen Some quick numbers Globally 40% of children are exposed to SHS 1 RCP report March 2010
More informationCentral pressures and prediction of cardiovascular events in erectile dysfunction patients
Central pressures and prediction of cardiovascular events in erectile dysfunction patients N. Ioakeimidis, K. Rokkas, A. Angelis, Z. Kratiras, M. Abdelrasoul, C. Georgakopoulos, D. Terentes-Printzios,
More informationTackling cancer inequalities in Scotland
7/7/21 Tackling cancer inequalities in Scotland Birmingham 17 th June 21 1 Absolute range: Healthy life expectancy Males Scotland 1999/ to 25/6 (Data not available 23/4) Source: Scottish Government Health
More informationSetting The setting was primary care. The economic study was carried out in the UK.
Cost-effectiveness of rosuvastatin, atorvastatin, simvastatin, pravastatin and fluvastatin for the primary prevention of CHD in the UK Davies A, Hutton J, O'Donnell J, Kingslake S Record Status This is
More informationCONTENT SUPPLEMENTARY FIGURE E. INSTRUMENTAL VARIABLE ANALYSIS USING DESEASONALISED PLASMA 25-HYDROXYVITAMIN D. 7
CONTENT FIGURES 3 SUPPLEMENTARY FIGURE A. NUMBER OF PARTICIPANTS AND EVENTS IN THE OBSERVATIONAL AND GENETIC ANALYSES. 3 SUPPLEMENTARY FIGURE B. FLOWCHART SHOWING THE SELECTION PROCESS FOR DETERMINING
More informationSupplementary Online Content
Supplementary Online Content McEvoy JW, Chen Y, Ndumele CE, et al. Six-year change in high-sensitivity cardiac troponin T and risk of subsequent coronary heart disease, heart failure, and death. JAMA Cardiol.
More informationWine, Alcohol, and Cardiovascular Health: Revisiting the Health Benefits of Wine in the Framingham Heart Study. Michael Darden and Douglas Nelson
http://www.davescampus.com/images/college-logos/tulane-university.j Wine Alcohol and Cardiovascular Health: Revisiting the Health Benefits of Wine in the Framingham Heart Study. Michael Darden and Douglas
More informationOutcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension
Outcomes and Perspectives of Single-Pill Combination Therapy for the modern management of hypertension Prof. Massimo Volpe, MD, FAHA, FESC, Chair of Cardiology, Department of Clinical and Molecular Medicine
More informationSupplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationType of intervention Primary prevention; secondary prevention. Economic study type Cost-effectiveness analysis and cost utility analysis.
A predictive model of the health benefits and cost effectiveness of celiprolol and atenolol in primary prevention of cardiovascular disease in hypertensive patients Milne R J, Hoorn S V, Jackson R T Record
More information